Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study

Restricted access

Object. By pursuing a policy of very early aneurysm treatment in neurosurgical centers, in-hospital rebleeds can be virtually eliminated. Nonetheless, as many as 15% of patients with aneurysm rupture suffer ultraearly rebleeding with high mortality rates, and these individuals are beyond the reach of even the most ambitious protocol for diagnosis and referral. Only drugs given immediately after the diagnosis of subarachnoid hemorrhage (SAH) has been established at the local hospital level can, in theory, contribute to the minimization of such ultraearly rebleeding. The object of this randomized, prospective, multicenter study was to assess the efficacy of short-term antifibrinolytic treatment with tranexamic acid in preventing rebleeding.

Methods. Only patients suffering SAH verified on computerized tomography (CT) scans within 48 hours prior to the first hospital admission were included. A 1-g dose of tranexamic acid was given intravenously as soon as diagnosis of SAH had been verified in the local hospitals (before the patients were transported), followed by doses of 1 g every 6 hours until the aneurysm was occluded; this treatment did not exceed 72 hours. In this study, 254 patients received tranexamic acid and 251 patients were randomized as controls. Age, sex, Hunt and Hess and Fisher grade distributions, as well as aneurysm locations, were congruent between the groups. Outcome was assessed at 6 months post-SAH by using the Glasgow Outcome Scale (GOS). Vasospasm and delayed ischemic neurological deficits were classified according to clinical findings as well as by transcranial Doppler (TCD) studies. All events classified as rebleeding were verified on CT scans or during surgery.

Conclusions. More than 90% of patients reached the neurosurgical center within 12 hours of their first hospital admission after SAH; 70% of all aneurysms were clipped or coils were inserted within 24 hours of the first hospital admission. Given the protocol, only one rebleed occurred later than 24 hours after the first hospital admission. Despite this strong emphasis on early intervention, however, a cluster of 27 very early rebleeds still occurred in the control group within hours of randomization into the study, and 13 of these patients died. In the tranexamic acid group, six patients rebled and two died. A reduction in the rebleeding rate from 10.8 to 2.4% and an 80% reduction in the mortality rate from early rebleeding with tranexamic acid treatment can therefore be inferred. Favorable outcome according to the GOS increased from 70.5 to 74.8%. According to TCD measurements and clinical findings, there were no indications of increased risk of either ischemic clinical manifestations or vasospasm that could be linked to tranexamic acid treatment. Neurosurgical guidelines for aneurysm rupture should extend also into the preneurosurgical phase to guarantee protection from ultraearly rebleeds. Currently available antifibrinolytic drugs can provide such protection, and at low cost. The number of potentially saved lives exceeds those lost to vasospasm.

Article Information

Address reprint requests to: Jan Hillman, M.D., Ph.D., Neurosurgical Department, University Hospital, S-581 85 Linköping, Sweden. email: jan.hillman@lio.se.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Graph showing the timing of admission for SAH to the primary referring hospital.

  • View in gallery

    Graph showing the timing of transportation from the primary referring hospital to the neurosurgical centers.

  • View in gallery

    Graphs showing the number of patients at risk for rebleeding after the first hospital admission and the number of recurrent hemorrhages in the control and antifibrinolytic groups.

References

1.

Bailes JESpetzler RFHadley MNet al: Management morbidity and mortality of poor-grade aneurysm patients. J Neurosurg 72:5595661990J Neurosurg 72:

2.

Bonita RThomson S: Subarachnoid hemorrhage: epidemiology, diagnosis, management, and outcome. Stroke 16:5915941985Stroke 16:

3.

Broderick JPBrott TGDuldner JEet al: Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 25:1342471994Stroke 25:

4.

Camarata PJHeros RCLatchaw RE: “Brain attack”: the rationale for treating stroke as a medical emergency. Neurosurgery 34:1441581994Neurosurgery 34:

5.

Chyatte DFode NCSundt TM Jr: Early versus late intracranial aneurysm surgery in subarachnoid hemorrhage. J Neurosurg 69:3263311988J Neurosurg 69:

6.

Edner GRonne-Engström E: Can early admission reduce aneurysmal rebleeds? A prospective study on aneurysmal incidence, aneurysmal rebleeds, admission and treatment delays in a defined region. Br J Neurosurg 5:6016081991Br J Neurosurg 5:

7.

Ekelund ASäveland HRomner Bet al: Is transcranial Doppler sonography useful in detecting late cerebral ischemia after aneurysmal subarachnoid hemorrhage? Br J Neurosurg 10:19251996Br J Neurosurg 10:

8.

Fisher CMKistler JPDavis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:191980Neurosurgery 6:

9.

Fodstad HLiliequist BSchannong Met al: Tranexamic acid in the preoperative management of ruptured intracranial aneurysms. Surg Neurol 10:9151978Surg Neurol 10:

10.

Fogelholm RHernesniemi JVapalahti M: Impact of early surgery on outcome after aneurysmal subarachnoid hemorrhage. A population-based study. Stroke 24:164916541993Stroke 24:

11.

Fridriksson SHillman JLandtblom AMet al: Education of referring doctors about sudden onset headache in subarachnoid hemorrhage. Acta Neurol Scand 103:2382422001Acta Neurol Scand 103:

12.

Fuiji YTakeuchi SSasaki Oet al: Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg 84:35421996J Neurosurg 84:

13.

Girvin JP: The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms. Trans Am Neurol Assoc 98:1501521973Girvin JP: The use of antifibrinolytic agents in the preoperative treatment of ruptured intracranial aneurysms. Trans Am Neurol Assoc 98:

14.

Grosset DGStraiton JMcDonald Iet al: Use of transcranial Doppler sonography to predict development of a delayed ischemic deficit after subarachnoid hemorrhage. J Neurosurg 78:1831871993J Neurosurg 78:

15.

Gumprecht HWinkler RGertstner Wet al: Therapeutic management of grade IV aneurysm patients. Surg Neurol 47:54591997Surg Neurol 47:

16.

Hadjivassiliou MTooth CLRomanowski CAet al: Aneurysmal SAH: cognitive outcome and structural damage after clipping or coiling. Neurology 56:167216772001Neurology 56:

17.

Hijdra ABraakman RVan Gijn Jet al: Aneurysmal subarachnoid hemorrhage. Complications and outcome in a hospital population. Stroke 18:106110671987Stroke 18:

18.

Hillman Jvon Essen CLeszniewski Wet al: Significance of “ultra-early” rebleeding in subarachnoid hemorrhage. J Neurosurg 68:9019071988J Neurosurg 68:

19.

Hunt WEHess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28:14201968J Neurosurg 28:

20.

Inagawa T: Effect of ultra-early referral on management outcome in subarachnoid haemorrhage. Acta Neurochir 136:51611995Inagawa T: Effect of ultra-early referral on management outcome in subarachnoid haemorrhage. Acta Neurochir 136:

21.

Inagawa T: Ultra-early rebleeding within six hours after aneurysmal rupture. Surg Neurol 42:1301341994Inagawa T: Ultra-early rebleeding within six hours after aneurysmal rupture. Surg Neurol 42:

22.

Inagawa TKamiya KOgasawara Het al: Rebleeding of ruptured intracranial aneurysms in the acute stage. Surg Neurol 28:93991987Surg Neurol 28:

23.

Inagawa TTokuda YOhbayashi Net al: Study of aneurysmal subarachnoid hemorrhage in Izumo City, Japan. Stroke 26:7617661995Stroke 26:

24.

Jakobsson KESäveland HHillman Jet al: Warning leak and management outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 85:9959991996J Neurosurg 85:

25.

Jane JAKassell NFTorner JCet al: The natural history of aneurysms and arteriovenous malformations. J Neurosurg 62:3213231985J Neurosurg 62:

26.

Jennett BBond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:4804841975Lancet 1:

27.

Juvela S: Rebleeding from ruptured intracranial aneurysms. Surg Neurol 32:3233261989Juvela S: Rebleeding from ruptured intracranial aneurysms. Surg Neurol 32:

28.

Kägstrom EPalma L: Influence of antifibrinolytic treatment on the morbidity in patients with subarachnoid hemorrhage. Acta Neurol Scand 48:2572651972Acta Neurol Scand 48:

29.

Kassell NFTorner JC: Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery 13:4794811983Neurosurgery 13:

30.

Kassell NFTorner JCAdams HP Jr: Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study. J Neurosurg 61:2252301984J Neurosurg 61:

31.

Kiyohara YUeda KHasuo Yet al: Incidence and prognosis of subarachnoid hemorrhage in a Japanese rural community. Stroke 20:115011551989Stroke 20:

32.

Leipzig TJRedelman KHorner TG: Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy. J Neurosurg 86:2202251997J Neurosurg 86:

33.

Le Roux PDElliott PJNewell DWet al: Predicting outcome in poor-grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurg 85:39491996J Neurosurg 85:

34.

Linn FHRinkel GJAlgra Aet al: The notion of “warning leaks” in subarachnoid haemorrhage: are such patients in fact admitted with a rebleed? J Neurol Neurosurg Psychiatry 68:3323362000J Neurol Neurosurg Psychiatry 68:

35.

Ljunggren BBrandt LKågström Eet al: Results of early operation for ruptured aneurysms. J Neurosurg 54:4734791981J Neurosurg 54:

36.

Ljunggren BSäveland HBrandt Let al: Early operation and overall outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 62:5475511985J Neurosurg 62:

37.

Maurice-Williams RSWadley JP: Delayed surgery for ruptured intracranial aneurysms: a reappraisal. Br J Neurosurg 11:1041091997Br J Neurosurg 11:

38.

Milhorat THKrautheim M: Results of early and delayed operations for ruptured intracranial aneurysms in two series of 100 consecutive patients. Surg Neurol 26:1231281986Surg Neurol 26:

39.

Morris KMShaw MDFoy PM: Ischaemic deterioration following aneurysmal subarachnoid haemorrhage: definition by clinical criteria. Br J Neurosurg 7:1491531993Br J Neurosurg 7:

40.

Mullan SDawley J: Antifibrinolytic therapy for intracranial aneurysms. J Neurosurg 28:21231968J Neurosurg 28:

41.

Nakagawa THashi K: The incidence and treatment of asymptomatic, unruptured cerebral aneurysms. J Neurosurg 80:2172231994J Neurosurg 80:

42.

Ohkuma HTsurutani HSuzuki S: Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke 32:117611802001Stroke 32:

43.

O'Neill PWest CRChadwick DWet al: Recurrent aneurysmal subarachnoid hemorrhage: incidence, timing and effects. A reappraisal in a surgical series. Br J Neurosurg 2:43481988Br J Neurosurg 2:

44.

Roos Y: Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group. Neurology 54:77822000Roos Y: Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group. Neurology 54:

45.

Roos YBBeenen LFGroen RJet al: Timing of surgery in patients with aneurysmal subarachnoid haemorrhage: rebleeding is still the major cause of poor outcome in neurosurgical units that aim at early surgery. J Neurol Neurosurg Psychiatry 63:4904931997J Neurol Neurosurg Psychiatry 63:

46.

Rosenörn JEskesen VSchmidt Ket al: The risk of rebleeding from ruptured intracranial aneurysms. J Neurosurg 67:3293321987J Neurosurg 67:

47.

Sarti CToumilehto JSalomaa Vet al: Epidemiology of subarachnoid hemorrhage in Finland from 1983 to 1985. Stroke 22:8488531991Stroke 22:

48.

Säveland HHillman JBrandt Let al: Overall outcome in aneurysmal subarachnoid hemorrhage. A prospective study from neurosurgical units in Sweden during a 1-year period. J Neurosurg 76:7297341992J Neurosurg 76:

49.

Säveland HSonesson BLjunggren Bet al: Outcome evaluation following subarachnoid hemorrhage. J Neurosurg 64:1911961986J Neurosurg 64:

50.

Seiler RWReulen HJHuber Pet al: Outcome of aneurysmal subarachnoid hemorrhage in a hospital population: a prospective study including early operation, intravenous nimodipine and transcranial Doppler ultrasound. Neurosurgery 23:5986041988Neurosurgery 23:

51.

Steiger HJFritschi JSeiler RW: Current pattern of in-hospital aneurysmal rebleeds. Analysis of a series treated with individually timed surgery and intravenous nimodipine. Acta Neurochir 127:21261994Acta Neurochir 127:

52.

Stroobandt GLambert OMenard E: The association of tranexamic acid and nimodipine in the pre-operative treatment of ruptured intracranial aneurysms. Acta Neurochir 140:1481601998Acta Neurochir 140:

53.

Taneda M: The significance of early operation in the management of ruptured intracranial aneurysms—an analysis of 251 cases hospitalized within 24 hours after subarachnoid haemorrhage. Acta Neurochir 63:2012081982Taneda M: The significance of early operation in the management of ruptured intracranial aneurysms—an analysis of 251 cases hospitalized within 24 hours after subarachnoid haemorrhage. Acta Neurochir 63:

54.

Torner JCKassell NFWallace RBet al: Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the Cooperative Aneurysm Study. Neurosurgery 9:5065131981Neurosurgery 9:

55.

Uski TKLilja ÅSäveland Het al: Cognitive functioning and cerebrospinal fluid concentrations of neuropeptides for patients in good neurological outcomes after aneurysmal subarachnoid hemorrhage. Neurosurgery 47:8128182000Neurosurgery 47:

56.

Vermeulen MLindsay KWMurray GDet al: Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med 311:4324371984N Engl J Med 311:

57.

Vermeulen Mvan Gijn JHijdra Aet al: Causes of acute deterioration in patients with a ruptured intracranial aneurysm. A prospective study with serial CT scanning. J Neurosurg 60:9359391984J Neurosurg 60:

58.

Whitfield PCMoss HO'Hare Det al: An audit of aneurysmal subarachnoid haemorrhage: earlier resuscitation and surgery reduces inpatient stay and deaths from rebleeding. J Neurol Neurosurg Psychiatry 60:3013061996J Neurol Neurosurg Psychiatry 60:

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 25 25 19
Full Text Views 262 262 70
PDF Downloads 131 131 43
EPUB Downloads 0 0 0

PubMed

Google Scholar